李楣,张丽丽,姚蓓,夏静,余文静,肖娟,候秋萍
LI Mei,ZHANG Lili,YAO Bei,XIA Jing,YU Wenjing,XIAO Juan,HOU Qiuping

• 1:重庆市第十三人民医院检验科

摘要(Abstract)：

目的:探究液基薄层细胞制片技术联合细胞DNA定量分析对良恶性胸腹水患者的诊断价值。方法:收集97例疑似肿瘤患者的胸腹水标本,以组织病理学诊断为标准,采用液基薄层细胞制片技术检查胸腹水中可疑癌细胞或癌细胞,采用福尔根染色法对胸腹水细胞DNA进行定量、计算DNA指数(DI)及DNA含量,分析上述2种方法单独检测及联合检测对良恶性病变的诊断符合率、灵敏度、特异度、阳性预测值及阴性预测值。结果:液基薄层细胞制片、细胞DNA定量分析分别与组织病理学诊断阳性率相比,差异均有统计学意义(P <0. 05); 2种方法联合检测的诊断符合率、诊断灵敏度和阴性预测值均分别高于液基薄层细胞制片和细胞DNA定量分析(P <0. 05)。结论:液基薄层细胞制片技术联合细胞DNA定量分析胸腹水良恶性性质具有较高的诊断符合率、灵敏度和阴性预测值。
Objective: To explore the diagnostic value of liquid-based thin layer cell sectioning technology combined with quantitative analysis of cellular DNA in patients with benign and malignant pleural and ascites. Methods: We collected the pleural and abdominal ascites specimens from 97 patients with suspected tumors based on histopathological diagnosis. Liquid-based thin-layer cell preparation technique was used to examine suspicious cancer cells or cancer cells in the pleural and ascites. DNA was quantified in cells in the pleural and ascites using Forgen staining. DNA index( DI)and DNA content were calculated. We compared the effect of the above two methods alone and their combination on diagnostic accuracy,sensitivity,specificity,positive predictive values and negative predictive values of detecting benign and malignant lesions. Results: Both liquid-based thin-layer cell preparation and quantitative analysis of cellular DNA were statistically different from the positive rate of histopathological diagnosis( P < 0. 05). The diagnostic coincidence rate,diagnostic sensitivity and the negative predictive values were higher in combination of two methods than those in liquid-based thin layer cell preparation or quantitative analysis of cellular DNA( P < 0. 05). Conclusion: Liquid-based thinlayer cell preparation technology combined with quantitative analysis of cell DNA for benign and malignant properties of pleural and ascites fluid has a high diagnostic coincidence rate,sensitivity and negative predictive value.

关键词(KeyWords)： 肿瘤;胸水;腹水;诊断;液基薄层细胞制片;DNA定量分析
neoplasms;hydrothorax;ascites;diagnosis;liquid-based thin layer cell sectioning;DNA quantitative analysis

Abstract:

Keywords:

基金项目(Foundation): 重庆市科卫联合医学科研项目(2018MSXM120)

作者(Author): 李楣,张丽丽,姚蓓,夏静,余文静,肖娟,候秋萍
LI Mei,ZHANG Lili,YAO Bei,XIA Jing,YU Wenjing,XIAO Juan,HOU Qiuping

DOI: 10.19367/j.cnki.2096-8388.2020.05.021

参考文献(References)：

• [1]陈越，郑军，谭潇．光动力疗法在肿瘤治疗中的研究进展[J]．实用医学杂志，2019,35(16):2517-2521.
• [2]王维飞，蒋宗惠，董祥宁，等．胃癌患者腹腔热灌注联合静脉化疗治疗恶性腹水的临床研究[J]．海军医学杂志，2018,39(2):188-190.
• [3]ALOREIDI K,GEDELA M,WABWIRE G,et al. Refractory hepatic hydrothorax in the absence of ascites as a first sign of cirrhosis[J]. South Dakota Journal of Medicine,2018,71(4):168-170.
• [4]李曼，石兴民，郭睿，等．胸腹水中肿瘤相关巨噬细胞不同活化亚型的分析[J]．国外医学(医学地理分册)，2019,40(2):120-123.
• [5]ZHU F L,LING A S,WEI Q,et al. Tumor markers in serum and ascites in the diagnosis of benign and malignant ascites[J]. Asian Pacific Journal of Cancer Prevention,2015,16(2):719-722.
• [6]李新玲．HC2-HPV DNA联合TCT检测早期诊断宫颈癌的价值[J]．医学新知杂志，2018,28(3):258-259.
• [7]ZHANG H,DU G,LIU Y F,et al. Overlay of a sponge soaked with ropivacaine and multisite infiltration analgesia result in faster recovery after laparoscopic hepatectomy[J]. World Journal of Gastroenterology,2019,25(34):5185-5196.
• [8]谢小林，刘家斌，张利．液基细胞学检查在恶性胸腹水鉴别诊断中的临床应用[J]．当代医学，2018,24(29):36-39.
• [9]汪少华，李丹，黄丛改，等．薄层液基细胞学联合DNA定量分析检测在肺癌中的诊断价值[J]．临床与实验病理学杂志，2019,35(7):832-834.
• [10]李玲义，张琪，姚文静，等．成人复杂性肺炎旁胸腔积液的治疗研究进展[J]．华南国防医学杂志，2018,32(5):351-354.
• [11]吴伟东，刘清峰，姜锋，等．基质金属蛋白酶在胸腔积液形成中作用的研究进展[J]．山东医药，2019,59(16):100-103.
• [12]刁彦文，董召，曲秀娟，等．腔内灌注贝伐单抗治疗恶性胸腹腔积液的研究进展[J]．现代肿瘤医学，2019,27(8):1441-1444.
• [13]郭金英，张开红，陈莎丽，等．血清、腹水中甲胎蛋白、癌胚抗原及癌抗原125检测对良、恶性腹水的诊断价值[J]．中国实用医刊，2019,46(10):42-44.
• [14]李相磊，孔瑞华，杨树利，等．比较胸腹水常规细胞学和液基细胞学在肿瘤细胞中的研究价值分析[J]．中国卫生检验杂志，2019,29(6):744-746.
• [15]许娟．细胞DNA倍体联合肿瘤标志物检测在良恶性胸腔积液、腹水鉴别中的应用价值[J]．检验医学与临床，2019,16(23):3469-3471.
• [16]NALWA A,WALIA R,SINGH V,et al. Comparison of conventional smear and liquid-based cytology preparation in diagnosis of lung cancer by bronchial wash and transbronchial needle aspiration[J]. Journal of Cytology,2018,35(2):94-98.
• [17]李维前，高立永，季洪菊等．两种膜式液基薄层细胞制片仪的应用对比研究[J]．中国医疗设备，2018,33(6):92-94.
• [18]INAGE T,NAKAJIMA T,YOSHINO I,et al. Early lung cancer detection[J]. Clinics in Chest Medicine,2018,39(1):45-55.
• [19]赵雪，杜广，李东等．DNA倍体分析系统在输尿管癌筛查及诊断中的应用[J]．临床和实验医学杂志，2019,18(11):1215-1217.
• [20]余晓川，毛怀凤，王婷等．300例藏族慢性乙肝患者血清标本乙肝病毒DNA定量与免疫学标志物检测的对比分析[J]．标记免疫分析与临床，2019,26(8):1334-1337.
• [21]张久荣，邹珏，林勇．DNA定量细胞学检查联合液基细胞学检测在胸腔积液鉴别诊断中的应用[J]．临床肺科杂志，2019,24(4):48-53.
• [22]张海彪．进展期胃癌患者手术前后脱落细胞及DNA异倍体阳性率分析[J]．肿瘤学杂志，2018,24(8):838-840.
• [23]马俊，王丽萍，黄玮，等．腹水脱落细胞DNA倍体对良恶性腹水的诊断价值研究[J]．佛山科学技术学院学报(自然科学版)，2018,36(3):69-72.
• [24]BISHT B,HANDA U,MOHAN H,et al. Complementary value of DNA flow cytometry and image morphometry in detection of malignant cells in effusion fluids[J]. The Malaysian Journal of Pathology,2014,36(2):83-90.
• [25]杨海．血液细胞形态学检查在血常规检测中的应用价值[J]．哈尔滨医药，2019,39(1):60-61.
• [26]周红儿．子宫上皮细胞稳定性FH检测与TCT检测在宫颈癌及癌前病变筛查中的诊断价值比较[J]．中国乡村医药，2019,26(12):54-55.
• [27]邹萍，胡怀远，宋瑞，等．液基薄层细胞学检测技术在肺癌诊断中的作用[J]．安徽医药，2018,22(1):105-108.
• [28]李攀，董莉萍，张晓波，等．脱落细胞涂片、DNA图像倍体分析和细胞块及其联合试验对恶性胸腔积液的诊断价值[J]．吉林大学学报(医学版)，2019,45(3):639-642.
• [29]蒋楠楠，邱伟东，刘集鸿，等．外周血异型淋巴细胞检查与EBV DNA定量检测在IM的早期诊断价值[J]．浙江临床医学，2018,20(7):1281-1283.
• [30]李雯，韩莉．TCT联合DNA细胞倍体筛查在宫颈病变诊断中的应用价值[J]．中国医药指南，2019,17(14):111-112.

文章评论(Comment)：